QA: Erasca Inc. in us_pharma/2022

Table of Contents

See also this year's filing and all EDGAR filings for this company.

PDF Report 0001761918_2023_Erasca_Inc.pdf

Logs

warning Missing logo subcommand.report {}

Graph

Absolute values for 0001761918, Erasca Inc.

  xvar xval
0 AssetsCurrent 444,496,000
1 IntangibleAssetsNetIncludingGoodwill 0
2 PropertyPlantAndEquipmentNet 24,815,000
3 remainder_Assets 45,598,000
4 LiabilitiesCurrent 48,690,000
5 LiabilitiesNoncurrent 54,366,000
6 remainder_Liabilities 0
7 CostOfGoodsAndServicesSold 0
8 SellingGeneralAndAdministrativeExpense 32,993,000
9 ResearchAndDevelopmentExpense 112,457,000
10 remainder_Expenses 102,000,000
11 remainder_Revenues 0
12 remainder_NetIncome 4,645,000
13 remainder_ComprehensiveNetIncome -879,000
  yvar yval
0 Assets 514,909,000
1 Liabilities 103,056,000
2 Expenses 247,450,000
3 Revenues 0
4 StockholdersEquity 411,853,000
5 NetIncome -242,805,000
6 ComprehensiveNetIncome -243,244,500
7 BaseVar 435,469,500
8 EconomicCapitalRatio 1.51

Edgar->Model Mapping

Feature Distribution

Change over Time